NV5 Announces Exceptional Fourth Quarter and Full Year 2017 Financial Results; Issues 2018 Guidance
Mar 08, 2018 21:01 pm UTC| Business
HOLLYWOOD, Fla., March 08, 2018 -- NV5 Global, Inc. (Nasdaq:NVEE) (“NV5” or the “Company”), a provider of professional and technical engineering and consulting solutions, today reported financial results for the fourth...
Finisar Announces Third Quarter Fiscal 2018 Financial Results
Mar 08, 2018 21:01 pm UTC| Business
SUNNYVALE, Calif., March 08, 2018 -- Finisar Corporation (NASDAQ:FNSR), a global technology leader for subsystems and components for fiber optic communications, today announced financial results for its third fiscal...
Pernix Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 08, 2018 21:01 pm UTC| Business
MORRISTOWN, N.J., March 08, 2018 -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today financial results for the three and twelve months ended December 31, 2017. ...
Ambac Announces Annual Meeting on May 18, 2018
Mar 08, 2018 21:01 pm UTC| Business
NEW YORK, March 08, 2018 -- Ambac Financial Group, Inc. (Nasdaq:AMBC) ("Ambac"), a holding company whose subsidiaries provide financial guarantees, announced today its Board of Directors set the date for the 2018 Annual...
Flexion Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 08, 2018 21:01 pm UTC| Business
Early launch activities for ZILRETTA® progressing well (strong clinical interest from prescribers; broad coverage from payers; encouraging feedback from patients) Company booked net ZILRETTA sales of approximately $355K...
Helix TCS Inc. and BioTrackTHC Sign Merger Agreement
Mar 08, 2018 21:01 pm UTC| Business
GREENWOOD VILLAGE, CO , March 08, 2018 -- Helix TCS, Inc. (OTCQB: HLIX) has signed a merger agreement with Bio-Tech Medical Software, Inc. dba BioTrackTHC. The combined company will trade under the Helix stock symbol,...
Coherus BioSciences Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 08, 2018 21:00 pm UTC| Business
REDWOOD CITY, Calif., March 08, 2018 -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today reviewed corporate events and reported financial results for the quarter and full year ended December 31, 2017. Fourth Quarter...
China Signals Subtle Treasury Pullback: Banks Urged to Ease US Debt Exposure
China Signals Quiet Treasury Trim: Banks Told to Ease Up on US Debt
The “Takaichi Trade”: How Japan’s First Female PM Is Shaping the Yen
How the US–India tariff truce boosts major Indian industries, Surat to Pharma